Boston Scientific Betting $1.5 Billion: Market Bets and Implications
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
This overview highlights the metrics that distinguish index and mutual funds, including costs, risk, and historical performance for informed choices.
25,005 articlesA bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
Investigating the royal bank (ry) 2026 Q2 results reveals how the lender is balancing growth across retail, wealth, a...
Microsoft has faced a recent pullback, but the company’s cloud, AI, and productivity strengths create a path to meani...
UPS has faced a rough stretch, but signs of a turnaround are catching investor attention. This guide explains why Jul...
A gold miner’s stock has doubled in 12 months and just raised its dividend by 60%. This deep-dive explains what drive...
Investors watching the EV and aerospace worlds know two things: Tesla and SpaceX sit at the frontier of tech. Could t...
As Omada Health eyes the 2025 earnings journey, investors want a clear read on growth, margins, and risks. This guide...
A single social post can move markets, but can it move your long-term returns? This article digs into the Apple-Intel...
A booming memory era presents both opportunities and risks for Micron. This guide breaks down the potential, the cata...
CoreWeave surged after its IPO, then pulled back. This guide breaks down how to think about buying the dip, with real...
A practical guide to interpreting Champions Oncology earnings. We break down the numbers, trends, and what to watch n...
Palantir faced a sharp 34% drop in the first half of 2026 as AI market expectations and earnings jitters weighed on s...